Due to the vast number of sphincterotome-related treatments that are carried out annually throughout the world, including anorectal surgeries such as Crohn's disease repair procedures and surgeries to correct hypopadias. Over the course of the projection period, this market segment is expected to be the top revenue generator in the industry due to the anticipated increase in demand for sphincterotome devices brought about by increased knowledge of the benefits of their use in operations.
In tandem with other core businesses, Olympus is a global leader in technology design and delivery. The company announced the launch of its StoneMasterV and VorticCatchV EndoTherapy devices, which increase the efficiency of bile duct stone management and retrieval for endoscopic retrograde cholangiopancreatography (ERCP).
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 3140
Published Date: Jan 05, 2024
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
AShift towards minimally invasive procedures, increase in ageing population, increase in medical expenditure and rising awareness regarding diseases are some of the major growth factors for sphincterotomes market.
The market size of sphincterotomes is anticipated to attain a CAGR of 4% over the forecast period, i.e., 2024 â€“ 2036.
The major players in the market are Boston Scientific Corporation, Medi-Globe GmbH, CONMED Corporation., ENDO-FLEX GmbH., Olympus America, Shaili Endoscopy, Bio Serve NZ Ltd, Advin Health Care, Micro-Tech (Nanjing) Co., Ltd, HOYA Corporation and others.
The pull type segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.